Clinical Trials Browser

Phase 2 × Completed × Neuromyelitis Optica × Clear all

NCT02166346 2018-04-17

Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch)

Phase 2 Completed

24 enrolled 10 charts

Myelitis, Myelitis, Transverse, Neuromyelitis Optica